drugset / Trial / NCT00130455
Treatment of Depression in the Elderly
Phase 4
Terminated
189 enrolled
Psychiatric Hospital, Hillerod
Amager Hospital · collabGeriatric Department,Korsør, Vestsjælland · collabPsychiatric Center Ballerup · collabPsychogeriatric Unit, CU Hospital, Frederiksberg · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is designed to establish the efficacy and tolerability of escitalopram in the treatment of depressive episodes of mild to moderate severity in the elderly. The study is designed as a mainly naturalistic study including all patients of 65 years of age or above that judged by the clinician would benefit from treatment by an antidepressant medication. The study is designed as a double-blind, randomised placebo controlled study with two groups of active treatment (escitalopram in two doses, 5 or 10 mg daily) in a twelve week period.
Timeline
- Start
- 2006-04
- Primary completion
- —
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 5 mg | — |
| Subject | Escitalopram | Small molecule | 10 mg | — |